9. Other Intangibles
The Company's intangible assets are finite-lived and amortized over their useful lives. Following is a summary of the Company's intangible assets as of March 2, 2013 and March 3, 2012.
| |
2013 | 2012 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |
Gross Carrying Amount |
Accumulated Amortization |
Remaining Weighted Average Amortization Period |
Gross Carrying Amount |
Accumulated Amortization |
Remaining Weighted Average Amortization Period | ||||||||||
|
Favorable leases and other |
$ | 623,541 | $ | (413,556 | ) | 10 years | $ | 614,862 | $ | (374,685 | ) | 10 years | ||||
|
Prescription files |
1,286,087 | (1,031,668 | ) | 4 years | 1,239,444 | (950,846 | ) | 5 years | ||||||||
|
Total |
$ | 1,909,628 | $ | (1,445,224 | ) | $ | 1,854,306 | $ | (1,325,531 | ) | ||||||
Also included in other non-current liabilities as of March 2, 2013 and March 3, 2012 are unfavorable lease intangibles with a net carrying amount of $70,195 and $82,030, respectively.
Amortization expense for these intangible assets and liabilities was $127,737, $143,790 and $173,618 for fiscal 2013, 2012 and 2011, respectively. The anticipated annual amortization expense for these intangible assets and liabilities is 2014—$104,289; 2015—$87,308; 2016—$76,037; 2017—$63,004 and 2018—$25,170.